MSB 2.17% $1.13 mesoblast limited

Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-253

  1. 5,696 Posts.
    lightbulb Created with Sketch. 2043
    You didn't provide a citation for this article. It says "No child has died from the COVID complication," but that is not true. 20 have died, that we know of:

    https://www.cdc.gov/mis-c/cases/index.html

    As for a free trial, that is already happening with our EAP for the use of Remestemcel-L in MIS-C.

    https://hotcopper.com.au/threads/ann-eap-for-remestemcel-l-in-children-with-mis-c-due-to-covid-19.5485389/




 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.